drugset / Trial / NCT04104685

A Study to Compare FCD105 Foam to Minocycline 3% Foam, Adapalene 0.3% Foam and Vehicle Foam.

NCT04104685

Phase 2 Completed 446 enrolled Vyne Therapeutics Inc.
RandomizedParallel-groupDouble-blindTreatment

Summary

A study comparing FCD105 to 3% minocycline foam, 0.3% adapalene foam and vehicle foam in patients ≥ 12 years old for the treatment of moderate-to-severe acne.

Timeline

Start
2019-09-18
Primary completion
2020-02-28
Completion
2020-03-03

Drugs

EvaluationDrugModalityDoseRoute
Comparator Adapalene Other / unclassified 0.3 % Topical
Comparator Minocycline Small molecule 3 % Topical

Indications